title: QTc prolongation: chlorpromazine and high-dosage olanzapine.
authors.forename: Irina
authors.initials: I
authors.lastname: Gurovich
authors.forename: Anitha
authors.initials: A
authors.lastname: Vempaty
authors.forename: Steven
authors.initials: S
authors.lastname: Lippmann
mesh_terms: D000368:Aged; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001569:Benzodiazepines; D004305:Dose-Response Relationship, Drug; D005260:Female; D006304:Health Status; D006801:Humans; D008133:Long QT Syndrome / Q000139:chemically induced* / Q000175:diagnosis; D000077152:Olanzapine; D010890:Pirenzepine / Q000008:administration & dosage / Q000009:adverse effects* / Q000031:analogs & derivatives*; D011618:Psychotic Disorders / Q000188:drug therapy*; D012720:Severity of Illness Index
chemical_list: D014150:Antipsychotic Agents; D001569:Benzodiazepines; D010890:Pirenzepine; D000077152:Olanzapine